BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma

被引：0

作者：

Shoko Nishizawa

Mamiko Sakata-Yanagimoto

Keiichiro Hattori

Hideharu Muto

Tran Nguyen

Koji Izutsu

Kenichi Yoshida

Seishi Ogawa

Naoya Nakamura

Shigeru Chiba

机构：

[1] University of Tsukuba,Department of Hematology, Comprehensive Human, Biosciences

[2] University of Tsukuba,Department of Hematology, Faculty of Medicine

[3] University of Tsukuba Hospital,Department of Hematology

[4] Toranomon Hospital,Department of Hematology

[5] Okinaka Memorial Institute for Medical Research,Department of Pathology and Tumor Biology

[6] Graduate School of Medicine,Department of Pathology

[7] Kyoto University,undefined

[8] Tokai University School of Medicine,undefined

来源：

International Journal of Hematology | 2017年 / 105卷

关键词：

Angioimmunoblastic T-cell lymphoma; BCL6 expression; Follicular helper T cells; Hypermethylation; mutation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

BCL6, a master transcription factor for differentiation of follicular helper T (TFH) cells, is highly expressed in angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphomas (PTCL) containing tumor cells with TFH features. TET2, encoding an epigenetic regulator, is frequently mutated in AITL/PTCL. We previously reported that Tet2 knockdown mice developed T-cell lymphomas with TFH features. Hypermethylation of the Bcl6 locus followed by BCL6 upregulation was thought to be the key event for lymphoma development in mice. The mechanisms by which BCL6 expression is upregulated in human AITL/PTCL, however, have not been elucidated. Here, we investigated the impact of TET2 mutations on methylation of BCL6 locus in human AITL/PTCL samples. Hypermethylation of the BCL6 locus was more frequent in PTCL samples than B-cell lymphoma samples (PTCL vs B-cell lymphomas: 9/42 vs 0/35). PTCL samples with TET2 mutations were more frequently hypermethylated than those without TET2 mutations (PTCL with TET2 mutations vs without mutations: 6/22 vs 0/17). BCL6 expression in hypermethylated samples was higher than that in low methylated samples. Deregulated BCL6 expression caused by hypermethylation and TET2 mutations may result in skewed TFH differentiation and eventually contribute to AITL/PTCL development in patients, as well as lymphoma development in Tet2 knockdown mice.

引用

页码：465 / 469

页数：4

共 94 条

[1]

de Leval L(2010)Advances in the understanding and management of angioimmunoblastic T-cell lymphoma Br J Haematol 148 673-689

[2]

Gisselbrecht C(2009)Bcl6 mediates the development of T follicular helper cells Science 325 1001-1005

[3]

Gaulard P(2013)New effector functions and regulatory mechanisms of BCL6 in normal and malignant lymphocytes Curr Opin Immunol 25 339-346

[4]

Nurieva RI(2008)Peripheral T-cell lymphoma with follicular T-cell markers Am J Surg Pathol 32 1787-1799

[5]

Chung Y(2012)Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters Blood 120 1466-1469

[6]

Martinez GJ(2016)The 2016 revision of the World Health Organization classification of lymphoid neoplasms Blood 127 2375-2390

[7]

Yang XO(2014)Somatic RHOA mutation in angioimmunoblastic T cell lymphoma Nat Genet 46 171-175

[8]

Tanaka S(2014)Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas Nat Genet 46 166-170

[9]

Matskevitch TD(2014)A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma Nat Genet 46 371-375

[10]

Bunting KL(2015)DNA methylation and hydroxymethylation in hematologic differentiation and transformation Curr Opin Cell Biol 37 91-101

← 1 2 3 4 5 6 7 8 9 10 →